www.fdanews.com/articles/84961-par-pharma-records-35m-quarterly-loss
PAR PHARMA RECORDS $35M QUARTERLY LOSS
March 1, 2006
Par Pharmaceutical Cos. reported today that it lost $34.9 million, or $1.02
a share, during the fourth quarter, brought down in large measure by charges
related to the sale of its FineTech Laboratories Ltd. unit. A year ago, Woodcliff
Lake, N.J.-based Par reported net income of $5.2 million, or 14 cents a share,
for the three months ending Dec. 31, 2004. Par has major operations in Chestnut
Ridge.
The
Journal News